Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells

Nagaraj Nagathihalli, Nadarajah Vigneswaran, Wolfgang Zacharias

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose: The death ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand) triggers apoptosis in a variety of cancer cells, which implies the potential for therapeutic applications. The purpose of this study was to investigate the role of the lysosomal protease cathepsin B (CB) in mediating TRAIL-induced cell death in oral squamous cell carcinoma (OSCC) cells. Methods: OSCC cell lines from primary tumor and lymph node metastasis were examined for expression of apoptosis markers by Western blots, enzyme activity assays, nuclear fragmentation assays, and FACS analysis. Gene-specific ribozymes or chemical inhibitors were used to inhibit CB or caspases in target cells. Results: TRAIL-induced activation of caspase-3, cleavage of Bid and poly-ADP-ribose polymerase, release of cytochrome c, and DNA fragmentation were blocked either by a pan-caspase inhibitor (zVAD-fmk) or a CB inhibitor (CA074Me), consistent with the involvement of TRAIL as well as CB in cell death. The primary tumor cells were more susceptible to apoptosis than their corresponding lymph node metastatic cells. Stable transfection of a ribozyme which inhibited CB expression also decreased the apoptotic process. Conclusions: We conclude that TRAIL-induced apoptotic cell death in OSCC cells is mediated through CB or through caspase activation. Our data point to a new tumor-suppressive role for CB in OSCC which is opposed to the invasion- and metastasis-promoting functions of lysosomal proteases.

Original languageEnglish (US)
Pages (from-to)171-183
Number of pages13
JournalJournal of Cancer Research and Clinical Oncology
Volume132
Issue number3
DOIs
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Cathepsin B
Mouth Neoplasms
Apoptosis
Squamous Cell Carcinoma
Catalytic RNA
Cell Death
Caspases
Peptide Hydrolases
Lymph Nodes
Neoplasm Metastasis
Ligands
Neoplasms
Caspase Inhibitors
Poly(ADP-ribose) Polymerases
Enzyme Assays
DNA Fragmentation
Cytochromes c
Tumor Cell Line
Caspase 3
Transfection

Keywords

  • Apoptosis
  • Caspases
  • Cathepsin B
  • Oral cancer
  • Ribozymes
  • TRAIL

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells. / Nagathihalli, Nagaraj; Vigneswaran, Nadarajah; Zacharias, Wolfgang.

In: Journal of Cancer Research and Clinical Oncology, Vol. 132, No. 3, 03.2006, p. 171-183.

Research output: Contribution to journalArticle

Nagathihalli, Nagaraj ; Vigneswaran, Nadarajah ; Zacharias, Wolfgang. / Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells. In: Journal of Cancer Research and Clinical Oncology. 2006 ; Vol. 132, No. 3. pp. 171-183.
@article{f58bb1cd31b4440ca0ec71ccde267880,
title = "Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells",
abstract = "Purpose: The death ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand) triggers apoptosis in a variety of cancer cells, which implies the potential for therapeutic applications. The purpose of this study was to investigate the role of the lysosomal protease cathepsin B (CB) in mediating TRAIL-induced cell death in oral squamous cell carcinoma (OSCC) cells. Methods: OSCC cell lines from primary tumor and lymph node metastasis were examined for expression of apoptosis markers by Western blots, enzyme activity assays, nuclear fragmentation assays, and FACS analysis. Gene-specific ribozymes or chemical inhibitors were used to inhibit CB or caspases in target cells. Results: TRAIL-induced activation of caspase-3, cleavage of Bid and poly-ADP-ribose polymerase, release of cytochrome c, and DNA fragmentation were blocked either by a pan-caspase inhibitor (zVAD-fmk) or a CB inhibitor (CA074Me), consistent with the involvement of TRAIL as well as CB in cell death. The primary tumor cells were more susceptible to apoptosis than their corresponding lymph node metastatic cells. Stable transfection of a ribozyme which inhibited CB expression also decreased the apoptotic process. Conclusions: We conclude that TRAIL-induced apoptotic cell death in OSCC cells is mediated through CB or through caspase activation. Our data point to a new tumor-suppressive role for CB in OSCC which is opposed to the invasion- and metastasis-promoting functions of lysosomal proteases.",
keywords = "Apoptosis, Caspases, Cathepsin B, Oral cancer, Ribozymes, TRAIL",
author = "Nagaraj Nagathihalli and Nadarajah Vigneswaran and Wolfgang Zacharias",
year = "2006",
month = "3",
doi = "10.1007/s00432-005-0053-9",
language = "English (US)",
volume = "132",
pages = "171--183",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells

AU - Nagathihalli, Nagaraj

AU - Vigneswaran, Nadarajah

AU - Zacharias, Wolfgang

PY - 2006/3

Y1 - 2006/3

N2 - Purpose: The death ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand) triggers apoptosis in a variety of cancer cells, which implies the potential for therapeutic applications. The purpose of this study was to investigate the role of the lysosomal protease cathepsin B (CB) in mediating TRAIL-induced cell death in oral squamous cell carcinoma (OSCC) cells. Methods: OSCC cell lines from primary tumor and lymph node metastasis were examined for expression of apoptosis markers by Western blots, enzyme activity assays, nuclear fragmentation assays, and FACS analysis. Gene-specific ribozymes or chemical inhibitors were used to inhibit CB or caspases in target cells. Results: TRAIL-induced activation of caspase-3, cleavage of Bid and poly-ADP-ribose polymerase, release of cytochrome c, and DNA fragmentation were blocked either by a pan-caspase inhibitor (zVAD-fmk) or a CB inhibitor (CA074Me), consistent with the involvement of TRAIL as well as CB in cell death. The primary tumor cells were more susceptible to apoptosis than their corresponding lymph node metastatic cells. Stable transfection of a ribozyme which inhibited CB expression also decreased the apoptotic process. Conclusions: We conclude that TRAIL-induced apoptotic cell death in OSCC cells is mediated through CB or through caspase activation. Our data point to a new tumor-suppressive role for CB in OSCC which is opposed to the invasion- and metastasis-promoting functions of lysosomal proteases.

AB - Purpose: The death ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand) triggers apoptosis in a variety of cancer cells, which implies the potential for therapeutic applications. The purpose of this study was to investigate the role of the lysosomal protease cathepsin B (CB) in mediating TRAIL-induced cell death in oral squamous cell carcinoma (OSCC) cells. Methods: OSCC cell lines from primary tumor and lymph node metastasis were examined for expression of apoptosis markers by Western blots, enzyme activity assays, nuclear fragmentation assays, and FACS analysis. Gene-specific ribozymes or chemical inhibitors were used to inhibit CB or caspases in target cells. Results: TRAIL-induced activation of caspase-3, cleavage of Bid and poly-ADP-ribose polymerase, release of cytochrome c, and DNA fragmentation were blocked either by a pan-caspase inhibitor (zVAD-fmk) or a CB inhibitor (CA074Me), consistent with the involvement of TRAIL as well as CB in cell death. The primary tumor cells were more susceptible to apoptosis than their corresponding lymph node metastatic cells. Stable transfection of a ribozyme which inhibited CB expression also decreased the apoptotic process. Conclusions: We conclude that TRAIL-induced apoptotic cell death in OSCC cells is mediated through CB or through caspase activation. Our data point to a new tumor-suppressive role for CB in OSCC which is opposed to the invasion- and metastasis-promoting functions of lysosomal proteases.

KW - Apoptosis

KW - Caspases

KW - Cathepsin B

KW - Oral cancer

KW - Ribozymes

KW - TRAIL

UR - http://www.scopus.com/inward/record.url?scp=29544431918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29544431918&partnerID=8YFLogxK

U2 - 10.1007/s00432-005-0053-9

DO - 10.1007/s00432-005-0053-9

M3 - Article

C2 - 16362335

AN - SCOPUS:29544431918

VL - 132

SP - 171

EP - 183

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 3

ER -